SII seeks DCGI’s permission for test license to manufacture Sputnik V COVID vaccine
New Delhi: Indian vaccine manufacturing company Serum Institute of India (SII) has sought permission from the Drug Controller General ...
New Delhi: Indian vaccine manufacturing company Serum Institute of India (SII) has sought permission from the Drug Controller General ...
The nod for Covishield came at the end of a marathon meeting of the SEC which began in the ...
Copyright 2022 © BM Global News. Enjoy our Latest World News.